Winner Profile
Pascal Soriot
CEO, AstraZeneca
Industry: Pharmaceuticals
Company size: XX-Large
Published: 2017-07-24
Is AstraZeneca a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Pascal Soriot (AstraZeneca) earned the following Obermatt pins for the management performance.
Obermatt accolades Pascal Soriot
| Year | Pin | Category |
|---|---|---|
| 2017 |  |
Investment Performance |
| 2015 |  |
Investment Performance |
Pascal Soriot was included in the competition among UK 100 Ranking (United Kingdom) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.
Performance Overview Pascal Soriot
In summary, Pascal Soriot obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 36 in Combined Performance indicates that Pascal Soriot was better than 36% of all other CEOs that were analyzed as part of the UK 100 Ranking – United Kingdom for four participations in Obermatt CEO competitions. Pascal Soriot’s average ranking can be found in the Multi-Year Rankings for UK 100 Ranking - United Kingdom.